133 related articles for article (PubMed ID: 36130981)
1. Diagnostic features and management options for duodenal neuroendocrine neoplasms: a retrospective, multi-centre study.
Mandair D; Kamieniarz L; Pizanias M; Weickert MO; Narayan A; O'Mahony LF; Caplin M; Ramage J; Prachalias A; Srirajaskanthan R; Toumpanakis C
Sci Rep; 2022 Sep; 12(1):15762. PubMed ID: 36130981
[TBL] [Abstract][Full Text] [Related]
2. Duodenal neuroendocrine neoplasms on enhanced CT: establishing a diagnostic model with duodenal gastrointestinal stromal tumors in the non-ampullary area and analyzing the value of predicting prognosis.
Feng N; Chen HY; Lu YF; Pan Y; Yu JN; Wang XB; Deng XY; Yu RS
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15143-15157. PubMed ID: 37634206
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of Duodenal Neuroendocrine Tumors: An Italian Multi-center Experience.
Massironi S; Campana D; Partelli S; Panzuto F; Rossi RE; Faggiano A; Brighi N; Falconi M; Rinzivillo M; Delle Fave G; Colao AM; Conte D
Ann Surg Oncol; 2018 Oct; 25(11):3200-3206. PubMed ID: 30054824
[TBL] [Abstract][Full Text] [Related]
4. Duodenal neuroendocrine neoplasms: a still poorly recognized clinical entity.
Rossi RE; Rausa E; Cavalcoli F; Conte D; Massironi S
Scand J Gastroenterol; 2018; 53(7):835-842. PubMed ID: 29726295
[TBL] [Abstract][Full Text] [Related]
5. Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy.
Rossi RE; Milanetto AC; Andreasi V; Campana D; Coppa J; Nappo G; Rinzivillo M; Invernizzi P; Modica R; David A; Partelli S; Lamberti G; Mazzaferro V; Zerbi A; Panzuto F; Pasquali C; Falconi M; Massironi S;
J Endocrinol Invest; 2021 Oct; 44(10):2227-2234. PubMed ID: 33651317
[TBL] [Abstract][Full Text] [Related]
6. The role of lymph node ratio in recurrence after curative surgery for pancreatic endocrine tumours.
Ricci C; Casadei R; Taffurelli G; Buscemi S; D'Ambra M; Monari F; Santini D; Campana D; Tomassetti P; Minni F
Pancreatology; 2013; 13(6):589-93. PubMed ID: 24280574
[TBL] [Abstract][Full Text] [Related]
7. [Non-functional duodenal neuroendocrine neoplasia in the proximal duodenum--case reports and proposal for a "high-risk-/low-risk-concept" in the decision for local endoscopic therapy].
Scheerer F; Schmitt W
Z Gastroenterol; 2013 Nov; 51(11):1240-50. PubMed ID: 24243571
[TBL] [Abstract][Full Text] [Related]
8. Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections.
Boninsegna L; Panzuto F; Partelli S; Capelli P; Delle Fave G; Bettini R; Pederzoli P; Scarpa A; Falconi M
Eur J Cancer; 2012 Jul; 48(11):1608-15. PubMed ID: 22129889
[TBL] [Abstract][Full Text] [Related]
9. Analysis of recurrence after resection of well-differentiated non-functioning pancreatic neuroendocrine tumors.
Tan QQ; Wang X; Yang L; Chen YH; Tan CL; Zhu XM; Ke NW; Liu XB
Medicine (Baltimore); 2020 Jun; 99(24):e20324. PubMed ID: 32541455
[TBL] [Abstract][Full Text] [Related]
10. Management and Prognosis of Localized Duodenal Neuroendocrine Neoplasms.
Gay-Chevallier S; de Mestier L; Perinel J; Forestier J; Hervieu V; Ruszniewski P; Millot I; Valette PJ; Pioche M; Lombard-Bohas C; Subtil F; Adham M; Walter T
Neuroendocrinology; 2021; 111(8):718-727. PubMed ID: 32335556
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic treatment of sporadic small duodenal and ampullary neuroendocrine tumors.
Gincul R; Ponchon T; Napoleon B; Scoazec JY; Guillaud O; Saurin JC; Ciocirlan M; Lepilliez V; Pioche M; Lefort C; Adham M; Pialat J; Chayvialle JA; Walter T
Endoscopy; 2016 Nov; 48(11):979-986. PubMed ID: 27494453
[No Abstract] [Full Text] [Related]
12. Surgical resection for duodenal neuroendocrine neoplasia: Outcome, prognostic factors and risk of metastases.
Nießen A; Bergmann F; Hinz U; Schimmack S; Hackert T; Büchler MW; Strobel O
Eur J Surg Oncol; 2020 Jun; 46(6):1088-1096. PubMed ID: 32088004
[TBL] [Abstract][Full Text] [Related]
13. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
[TBL] [Abstract][Full Text] [Related]
14. A "Watch and Wait" Strategy Involving Regular Endoscopic Surveillance Is Safe for Many Patients with Small, Sporadic, Grade 1, Non-Ampullary, Non-Functioning Duodenal Neuroendocrine Tumours.
Exarchou K; Moore AR; Smart HL; Duckworth CA; Howes N; Pritchard DM
Neuroendocrinology; 2021; 111(8):764-774. PubMed ID: 32937631
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Recurrence Between Pancreatic and Duodenal Neuroendocrine Neoplasms After Curative Resection: A Single-Institution Analysis.
Masui T; Sato A; Nakano K; Uchida Y; Yogo A; Anazawa T; Nagai K; Kawaguchi Y; Takaori K; Uemoto S
Ann Surg Oncol; 2018 Feb; 25(2):528-534. PubMed ID: 29164413
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Role of Examined and Positive Lymph Nodes after Distal Pancreatectomy for Non-Functioning Neuroendocrine Neoplasms.
Guarneri G; de Mestier L; Landoni L; Partelli S; Gaujoux S; Andreasi V; Nessi C; Dokmak S; Fontana M; Dousset B; Ruszniewski P; Bassi C; Falconi M; Sauvanet A
Neuroendocrinology; 2021; 111(8):728-738. PubMed ID: 32585667
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of the Ki67 index for lymph node metastasis of small non-functioning pancreatic neuroendocrine neoplasms.
Masui T; Sato A; Nakano K; Uchida Y; Yogo A; Anazawa T; Nagai K; Kawaguchi Y; Takaori K; Uemoto S
Surg Today; 2019 Jul; 49(7):593-600. PubMed ID: 30838442
[TBL] [Abstract][Full Text] [Related]
18. The number of positive nodes accurately predicts recurrence after pancreaticoduodenectomy for nonfunctioning neuroendocrine neoplasms.
Partelli S; Javed AA; Andreasi V; He J; Muffatti F; Weiss MJ; Sessa F; La Rosa S; Doglioni C; Zamboni G; Wolfgang CL; Falconi M
Eur J Surg Oncol; 2018 Jun; 44(6):778-783. PubMed ID: 29610023
[TBL] [Abstract][Full Text] [Related]
19. Number of Positive Lymph Nodes Is Superior to LNR and LODDS for Predicting the Prognosis of Pancreatic Neuroendocrine Neoplasms.
Gao B; Zhou D; Qian X; Jiang Y; Liu Z; Zhang W; Wang W
Front Endocrinol (Lausanne); 2021; 12():613755. PubMed ID: 33746899
[TBL] [Abstract][Full Text] [Related]
20. Duodenal neuroendocrine neoplasms with unexpectedly aggressive behaviour: Challenging the "watch and wait" approach.
Ratnayake GM; Srirajaskanthan R; Luong T; Gnanasegaran G; Toumpanakis C
J Neuroendocrinol; 2022 Jan; 34(1):e13067. PubMed ID: 34914146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]